Insulin receptor substrate 1 (IRS-1) is one of the major substrates of insulin receptor tyrosine kinase and mediates multiple insulin signals downstream. We have previously shown that the levels of IRS-1 mRNA varied in different tissues. To elucidate the molecular mechanisms of the tissue specific regulation of IRS-1, we have studied the cis-acting elements and transacting factors in CHO and HepG2 cells. Using the chloramphenicol acetyltransferase (CAT) assay with the various deletion mutants of the IRS-1 promoter–CAT fusion plasmids, several regions responsible for positive or negative regulation in each cell line were identified. A region from −1645 to −1585 bp, which regulated expression negatively in CHO cells and positively in HepG2 cells, was further analyzed. Within this region sa fragment from −1645 to −1605 bp upregulated the IRS-1 promoter only in HepG2 cells, whereas a fragment from −1605 to −1585 bp downregulated only in CHO cells. In the gel mobility shift assay, several nuclear proteins that bind to these fragments were detected, and among them, two nuclear proteins that bind to a potential E box (nucleotide [nt] −1635 to −1630) and two nuclear proteins that bind to a potential C/EBP binding site (nt −1599 to −1591) were identified in HepG2 and CHO cells, respectively. CAT assays using promoters mutated at the E box or at the C/EBP binding site revealed that these sequences were responsible for cell-specific regulation of the IRS-1 gene. We therefore concluded that the two nuclear proteins that bind to the E box regulate IRS-1 gene expression positively in HepG2 cells and the two nuclear proteins that bind to the C/EBP binding site regulate it negatively in CHO cells.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1997
Cell-Specific Regulation of IRS-1 Gene Expression: Role of E Box and C/EBP Binding Site in HepG2 Cells and CHO Cells
Kohji Matsuda;
Kohji Matsuda
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Eiichi Araki;
Eiichi Araki
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Ryohei Yoshimura;
Ryohei Yoshimura
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Kaku Tsuruzoe;
Kaku Tsuruzoe
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Noboru Furukawa;
Noboru Furukawa
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Kengo Kaneko;
Kengo Kaneko
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Hiroyuki Motoshima;
Hiroyuki Motoshima
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Kazuaki Yoshizato;
Kazuaki Yoshizato
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Kishikawa Hideki;
Kishikawa Hideki
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Motoaki Shichiri
Motoaki Shichiri
From the Department of Metabolic Medicine, Kumamoto University School of Medicine
Kumamoto, Japan
Search for other works by this author on:
Address correspondence and reprint requests to Eiichi Araki, Department of Metabolic Medicine, Kumamoto University School of Medicine, 1-1-1, Honjo, Kumamoto, 860, Japan.
1
bHLH, basic helix-loop-helix; CAT, chloramphenicol acetyltransferase; CREB, cAMP responsive element binding protein; IRS-1, insulin receptor substrate 1; MBP, maltose binding protein; nt, nucleotide.
Diabetes 1997;46(3):354–362
Article history
Received:
August 28 1996
Revision Received:
October 30 1996
Accepted:
October 30 1996
PubMed:
9032089
Citation
Kohji Matsuda, Eiichi Araki, Ryohei Yoshimura, Kaku Tsuruzoe, Noboru Furukawa, Kengo Kaneko, Hiroyuki Motoshima, Kazuaki Yoshizato, Kishikawa Hideki, Motoaki Shichiri; Cell-Specific Regulation of IRS-1 Gene Expression: Role of E Box and C/EBP Binding Site in HepG2 Cells and CHO Cells. Diabetes 1 March 1997; 46 (3): 354–362. https://doi.org/10.2337/diab.46.3.354
Download citation file:
63
Views